camptothecin has been researched along with Bladder Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beijnen, JH; Breda, M; Fraier, D; Grazia Porro, M; Jansen, S; Lieverst, J; Pellizzoni, C; Rosing, H; Schellens, JH; Schoemaker, NE; Spinelli, R; Swart, M; ten Bokkel Huinink, WW; van Kesteren, C | 1 |
1 trial(s) available for camptothecin and Bladder Diseases
| Article | Year |
|---|---|
A phase I and pharmacokinetic study of MAG-CPT, a water-soluble polymer conjugate of camptothecin.
Topics: Acrylamides; Adult; Aged; Antineoplastic Agents, Phytogenic; Camptothecin; Female; Hematologic Diseases; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Urinary Bladder Diseases | 2002 |